FTO and Parkinson disease: More recently, based on structure-based virtual screening and a series of in vivo and in vitro experiments, Peng et al. discovered that entacapone, which was previously approved for the treatment of Parkinson's disease by the Food and Drug Administration (FDA), can be used as a specific inhibitor of FTO.